Search Results
91 results
Your search is now limited to «New Treatments» expert search.
Genetic Literacy Project 04/19/2019 07:01
Such research might lead to new therapies for stroke and other conditions, as well as provide a new way to study the brain and how drugs work in it, researchers said.
More from Genetic Literacy Project:
WN.com 04/18/2019 18:49
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research.
More from WN.com:
PR Newswire 04/17/2019 20:08
Leveraging the platform, the company has built up a robust pipeline of 20 innovative assets in the fields of oncology, ophthalmology, autoimmunity, and cardiovascular diseases.
More from PR Newswire:
The primary outcome is defined as time to a first event of either a cardiovascular death or kidney disease progression, defined as end-stage kidney disease (the need for kidney replacement therapy such as, dialysis or kidney transplantation), a sustained decline in eGFR to 2, renal death or a sustained decline of ≥40 percent in eGFR from randomisation.
More from Middle East North Africa Financial Network (MENAFN):
News-Medical.net 04/15/2019 01:39
Novo Biosciences achieves major milestones in its new drug to treat heart disease and DMD.
More from News-Medical.net:
Daiichi Sankyo (Japan) 04/14/2019 11:00
Daiichi Sankyo expects the drug to benefit patients in Japan by providing a new therapeutic option for the treatment of peripheral neuropathic pain.
More from Daiichi Sankyo (Japan):
Drugs.com 04/08/2019 23:04
About Daiichi Sankyo Cancer Enterprise The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer.
More from Drugs.com:
Cefiderocol has broad Gram-negative antimicrobial activity against all the critical Gram-negative pathogens the World Health Organization has identified as being the highest priority for finding new treatment options.
More from Global Banking & Finance Review (UK):
The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse any information, drugs, therapies, treatments, products, processes, or services.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications